A
Abigail Clutterbuck-James
Researcher at Papworth Hospital
Publications - 10
Citations - 289
Abigail Clutterbuck-James is an academic researcher from Papworth Hospital. The author has contributed to research in topics: Continuous positive airway pressure & Randomized controlled trial. The author has an hindex of 4, co-authored 10 publications receiving 229 citations.
Papers
More filters
Journal ArticleDOI
Meta-analysis of randomised controlled trials of oral mandibular advancement devices and continuous positive airway pressure for obstructive sleep apnoea-hypopnoea.
Linda D. Sharples,Linda D. Sharples,Abigail Clutterbuck-James,Matthew Glover,Maxine Bennett,Rebecca Chadwick,Marcus Pittman,Timothy G. Quinnell +7 more
TL;DR: Although CPAP has a greater treatment effect, MAD is an appropriate treatment for patients who are intolerant of CPAP and may be comparable to CPAP in mild disease.
Journal ArticleDOI
A crossover randomised controlled trial of oral mandibular advancement devices for obstructive sleep apnoea-hypopnoea (TOMADO)
Timothy G. Quinnell,Maxine Bennett,Jake Jordan,Abigail Clutterbuck-James,Mike Davies,Ian Smith,Nicholas Oscroft,Marcus Pittman,Malcolm Cameron,Rebecca Chadwick,Mary J. Morrell,Matthew Glover,Julia Fox-Rushby,Linda D. Sharples +13 more
TL;DR: Non-adjustable MADs achieve clinically important improvements in mild to moderate OSAHS and are cost-effective and the semi-bespoke MAD is an appropriate first choice.
Journal ArticleDOI
Clinical effectiveness and cost-effectiveness results from the randomised controlled Trial of Oral Mandibular Advancement Devices for Obstructive sleep apnoea-hypopnoea (TOMADO) and long-term economic analysis of oral devices and continuous positive airway pressure.
Linda D. Sharples,Matthew Glover,Abigail Clutterbuck-James,Maxine Bennett,Jake Jordan,Rebecca Chadwick,Marcus Pittman,Clare East,Malcolm Cameron,Mike Davies,Nick Oscroft,Ian Smith,Mary J. Morrell,Julia Fox-Rushby,Timothy G. Quinnell +14 more
TL;DR: A randomised controlled trial examining the clinical effectiveness and cost-effectiveness of MADs against no treatment in mild to moderate OSAH and newly published results to better inform long-term clinical effectiveness
Journal ArticleDOI
Alternatives to continuous positive airway pressure 2: mandibular advancement devices compared.
TL;DR: There is now a growing body of evidence suggesting that MADs are a clinically and cost-effective treatment for OSA; and in some cases, patient preference may make them a better option than CPAP.
Journal ArticleDOI
Tomado: a crossover randomised controlled trial of oral mandibular advancement devices for obstructive sleep apnoea-hypopnoea
Timothy G. Quinnell,Marcus Pittman,Maxine Bennett,Jake Jordan,Abigail Clutterbuck-James,Clare East,Mike Davies,Nick Oscroft,Malcolm Cameron,Rebecca Chadwick,Ian Smith,Mary J. Morrell,Matthew Glover,Julia Fox-Rushby,Linda D. Sharples +14 more
TL;DR: Mandibular Advancement Devices achieve clinically important improvements in mild to moderate OSAH syndrome and are cost effective, according to mean costs and QALYs.